Table VI.
Group | NO (µmol/l) | SOD (U/ml) | GSH-Px (U/ml) | GS (mg/l) | MDA (nmol/ml) |
---|---|---|---|---|---|
Normal | 1.56±0.06b | 81.32±2.18b | 117.59±8.06b | 6.68±0.20a | 0.55±0.07b |
Model | 8.71±0.23 | 18.24±0.89 | 38.93±1.48 | 2.00±0.15 | 4.70±0.15 |
Vc | 5.52±0.12a | 48.38±2.12a | 69.69±3.27a | 4.23±0.15a | 2.13±0.07a |
AVP-L | 6.91±0.09a | 28.87±1.18a | 55.87±2.59a | 3.21±0.15a | 3.43±0.22a |
AVP-H | 4.20±0.16a | 70.69±2.22b | 92.62±2.67b | 5.37±0.20a | 1.12±0.05a |
Values are presented as the mean ± standard deviation (N=10/group).
P<0.05
P<0.01 vs. the model group. Vc, mice treated with Vc (100 mg/kg); AVP-L, mice treated with low concentration of AVP (50 mg/kg); AVP-H, mice treated with a high concentration of AVP (100 mg/kg). AVP, Apocynum venetum polyphenol extract; GSH, glutathione; GSH-Px, glutathione peroxidase; MDA, malondialdehyde; NO, nitric oxide; SOD, superoxide dismutase; Vc, vitamin C.